Affimed N.V.
AFMD · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $8 | $41 | $40 | $28 |
| % Growth | -80% | 2.4% | 42.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $8 | $41 | $40 | $28 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $95 | $99 | $81 | $50 |
| G&A Expenses | $25 | $32 | $24 | $14 |
| SG&A Expenses | $25 | $32 | $24 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5 | $0 | $0 | $1 |
| Operating Expenses | $115 | $131 | $106 | $64 |
| Operating Income | -$107 | -$88 | -$64 | -$35 |
| % Margin | -1,289% | -213.1% | -158.6% | -122.4% |
| Other Income/Exp. Net | $1 | $2 | $7 | -$7 |
| Pre-Tax Income | -$106 | -$86 | -$58 | -$41 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$106 | -$86 | -$58 | -$41 |
| % Margin | -1,280.2% | -208% | -142.5% | -145.9% |
| EPS | -7.09 | -6.04 | -4.81 | -4.96 |
| % Growth | -17.4% | -25.6% | 3% | – |
| EPS Diluted | -7.09 | -6.04 | -4.81 | -4.96 |
| Weighted Avg Shares Out | 15 | 14 | 12 | 8 |
| Weighted Avg Shares Out Dil | 15 | 14 | 12 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | -$0 | $0 |
| Interest Expense | $2 | $2 | $1 | $0 |
| Depreciation & Amortization | $2 | $3 | $1 | $1 |
| EBITDA | -$102 | -$81 | -$55 | -$40 |
| % Margin | -1,237.2% | -197% | -137.3% | -141.9% |